Association between vitamin D receptor FokI polymorphism and hypertension in Indonesian ischemic stroke patients: a cross-sectional study
Abstract
Background: Vitamin D receptor (VDR) FokI polymorphism (rs2228570) affects VDR protein transcriptional activity and may influence hypertension risk through renin-angiotensin system modulation. However, evidence in Southeast Asian stroke populations remains limited.
Objective: To investigate the association between VDR FokI polymorphism and hypertension in Indonesian ischemic stroke patients.
Methods: This cross-sectional study enrolled 85 ischemic stroke patients (50 hypertensive, 35 normotensive) from Medan, Indonesia. VDR FokI genotypes (CC, CT, TT) were determined using PCR-RFLP. Association with hypertension was analyzed using chi-square test.
Results: Genotype distribution showed CC and CT at equal frequency (44.7% each) and TT at 10.6%, with corresponding C and T allele frequencies of 67.1% and 32.9%, respectively. Among hypertensive stroke patients, CT genotype predominated (52.0%), whereas CC genotype was most prevalent in normotensive patients (57.1%). Despite these distributional differences, no significant association was observed between VDR FokI polymorphism and hypertension (χ² = 3.732, p = 0.155).
Conclusion: VDR FokI polymorphism was not significantly associated with hypertension in Indonesian ischemic stroke patients, suggesting that genetic predisposition via this single polymorphism may be overshadowed by established stroke pathophysiology or complex gene-environment interactions in this specific clinical context.
References
Al-Oanzi ZH, Tuck SP, Raj N, Harrop J, Summers GD, Cook DB, et al. Assessment of vitamin D status in male osteoporosis. Calcif Tissue Int. 2017;100(6):590-597.
Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009;94(10):4023-4030. https://doi.org/10.1210/jc.2008-1212
Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, et al. Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocr Rev. 2019;40(4):1109-1151. https://doi.org/10.1210/er.2018-00126
Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92(2):77-98. https://doi.org/10.1007/s00223-012-9619-0
Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: Meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28(3):205-221. https://doi.org/10.1007/s10654-013-9790-2
Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol. 2016;13(7):404-417. https://doi.org/10.1038/nrcardio.2016.73
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D₃ is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-238. https://doi.org/10.1172/JCI0215219
Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)₂D₃-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice. Kidney Int. 2008;74(2):170-179. https://doi.org/10.1038/ki.2008.101
Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143-156. https://doi.org/10.1016/j.gene.2004.05.014
Prabhakar P, Majumdar V, Kulkarni GB, Christopher R. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. Biochem Biophys Res Commun. 2015;456(2):631-636. https://doi.org/10.1016/j.bbrc.2014.12.007
Tabaei S, Motallebnezhad M, Tabaee SS. Vitamin D Receptor (VDR) gene polymorphisms and risk of coronary artery disease (CAD): Systematic review and meta-analysis. Biochem Genet. 2021;59(4):813-836. https://doi.org/10.1007/s10528-021-10038-x
Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res. 1997;12(6):915-921. https://doi.org/10.1359/jbmr.1997.12.6.915
Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177(1-2):145-159. https://doi.org/10.1016/S0303-7207(01)00406-3
Rahman MM, Hosen MB, Islam MS, Islam MS, Fariha KA, Nafisa T, et al. Association between vitamin D receptor gene polymorphism and essential hypertension: An updated systematic review, meta-analysis, and meta-regression. PLoS One. 2024;19(12):e0315657. https://doi.org/10.1371/journal.pone.0314886
Khan MS, Islam MR, Akash S, Bin Jardan YA, Biswas P, Rauf A, et al. Polymorphisms of vitamin D receptor gene and their association with essential hypertension in Bangladeshi population: A case-control study. BMC Med Genomics. 2024;17(1):15.
Swapna N, Padma T, Vamsi UM, Usha G. Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Indian J Hum Genet. 2011;17(3):201-205. https://doi.org/10.4103/0971-6866.92104
Cottone S, Guarino L, Arsena R, Scazzone C, Tornese F, Mulé G. FokI and BsmI vitamin D receptor polymorphisms in hypertensive patients. Am J Hypertens. 2015;28(12):1438-1444.
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://doi.org/10.1016/j.jacc.2017.11.006
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820. https://doi.org/10.1016/S1474-4422(21)00252-0
Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97(20 Suppl 2):S6-S16. https://doi.org/10.1212/WNL.0000000000012781
Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2013. Laporan Nasional 2013. Jakarta: Kementerian Kesehatan Republik Indonesia; 2013.
Kemenkes RI. Situasi kesehatan jantung. Pusat Data dan Informasi Kementerian Kesehatan RI; 2014.
O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet. 2016;388(10046):761-775. https://doi.org/10.1016/S0140-6736(16)30506-2
Serra MO, de Macedo LR, Silva M, Lautner RQ. Effect of vitamin D supplementation on blood pressure in hypertensive individuals with hypovitaminosis D: A systematic review and meta-analysis. J Hypertens. 2024;42(4):594-604. https://doi.org/10.1097/HJH.0000000000003646
Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2022;21(10):891-911.
Goel RK, Lal H. Role of vitamin D supplementation in hypertension. Indian J Endocrinol Metab. 2011;15(4):S238-S247.
Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, et al. 1,25-Dihydroxyvitamin D₃ suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007;282(41):29821-29830. https://doi.org/10.1074/jbc.M705495200
Kong J, Zhu X, Shi Y, Liu T, Chen Y, Bhan I, et al. VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Mol Endocrinol. 2013;27(12):2116-2125. https://doi.org/10.1210/me.2013-1146
Copyright (c) 2026 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
